INTRODUCTION: Lung cancer is a disease of high symptom burden, major psychosocial impact and poor prognosis. Although diagnosis is individual, each patient operates within a social context. Patient perception of family's or friends' concern may affirm the presence of support or may drive personal anxiety. Perceived worry may impact on freedom to discuss illness or symptoms within the support network. The validated palliative outcome scale quantifies physical and psychosocial needs. It also evaluates anxiety felt and anxiety perceived in the support network. This study examined lung cancer patients' symptoms, performance status, their supportive care needs and their perception of family's/friends' anxiety. GOALS OF WORK: The aim of this study was to evaluate lung cancer patients' anxiety, physical symptoms, performance status and their perception of anxiety within their support network. PATIENTS AND METHODS: The study was a prospective observational evaluation of 170 lung cancer out-patients using an adapted palliative outcome scale questionnaire. Comparison was made between patients perceiving high anxiety within their support network and those who perceiving low anxiety. MAIN RESULTS: Perceived familial and self-rated personal anxiety both increased as function declined (p < 0.001; p = 0.001). Increased perceived worry was associated with increased physical symptoms [dyspnoea (p < 0.001), cough (p = 0.001), haemoptysis (p = 0.009)], low self-esteem (p = 0.004) and feeling lack of worth (p = 0.035). Perception of increased worry did not influence whether patients felt able to share their feelings (p = 0.362). CONCLUSIONS: As physical function declines and symptoms increase, patients are more worried themselves and perceive increased anxiety within their support network. However, this circle of anxiety did not impair the perception that feelings could be shared within the support network.
INTRODUCTION:Lung cancer is a disease of high symptom burden, major psychosocial impact and poor prognosis. Although diagnosis is individual, each patient operates within a social context. Patient perception of family's or friends' concern may affirm the presence of support or may drive personal anxiety. Perceived worry may impact on freedom to discuss illness or symptoms within the support network. The validated palliative outcome scale quantifies physical and psychosocial needs. It also evaluates anxiety felt and anxiety perceived in the support network. This study examined lung cancerpatients' symptoms, performance status, their supportive care needs and their perception of family's/friends' anxiety. GOALS OF WORK: The aim of this study was to evaluate lung cancerpatients' anxiety, physical symptoms, performance status and their perception of anxiety within their support network. PATIENTS AND METHODS: The study was a prospective observational evaluation of 170 lung cancer out-patients using an adapted palliative outcome scale questionnaire. Comparison was made between patients perceiving high anxiety within their support network and those who perceiving low anxiety. MAIN RESULTS: Perceived familial and self-rated personal anxiety both increased as function declined (p < 0.001; p = 0.001). Increased perceived worry was associated with increased physical symptoms [dyspnoea (p < 0.001), cough (p = 0.001), haemoptysis (p = 0.009)], low self-esteem (p = 0.004) and feeling lack of worth (p = 0.035). Perception of increased worry did not influence whether patients felt able to share their feelings (p = 0.362). CONCLUSIONS: As physical function declines and symptoms increase, patients are more worried themselves and perceive increased anxiety within their support network. However, this circle of anxiety did not impair the perception that feelings could be shared within the support network.
Authors: E L Smith; D M Hann; T A Ahles; C T Furstenberg; T A Mitchell; L Meyer; L H Maurer; J Rigas; S Hammond Journal: J Pain Symptom Manage Date: 2001-04 Impact factor: 3.612
Authors: Carol Tishelman; Lesley F Degner; Ann Rudman; Kristina Bertilsson; Ruth Bond; Eva Broberger; Eva Doukkali; Helena Levealahti Journal: Cancer Date: 2005-11-01 Impact factor: 6.860
Authors: U Khalid; A Spiro; C Baldwin; B Sharma; C McGough; A R Norman; T Eisen; M E R O'Brien; D Cunningham; H J N Andreyev Journal: Support Care Cancer Date: 2006-06-20 Impact factor: 3.603
Authors: Terence T Sio; Pamela J Atherton; Levi D Pederson; W Ken Zhen; Robert W Mutter; Yolanda I Garces; Daniel J Ma; James L Leenstra; Jean-Claude M Rwigema; Shaker Dakhil; James D Bearden; Sonja J van der Veen; Apar K Ganti; Steven E Schild; Robert C Miller Journal: Int J Radiat Oncol Biol Phys Date: 2018-11-02 Impact factor: 7.038
Authors: Amy E Lowery; Paul Krebs; Elliot J Coups; Marc B Feinstein; Jack E Burkhalter; Bernard J Park; Jamie S Ostroff Journal: Support Care Cancer Date: 2013-09-10 Impact factor: 3.603
Authors: Michèle Aubin; Lucie Vézina; René Verreault; Lise Fillion; Eveline Hudon; François Lehmann; Yvan Leduc; Rénald Bergeron; Daniel Reinharz; Diane Morin Journal: Support Care Cancer Date: 2010-09-30 Impact factor: 3.603
Authors: Grace E Dean; Nancy S Redeker; Ya-Jung Wang; Ann E Rogers; Suzanne S Dickerson; Lynn M Steinbrenner; Nalaka S Gooneratne Journal: Oncol Nurs Forum Date: 2013-09 Impact factor: 2.172
Authors: Kathleen G Hopkins; Leslie A Hoffman; Annette De Vito Dabbs; Peter F Ferson; Linda King; Linda A Dudjak; Thomas G Zullo; Margaret Q Rosenzweig Journal: J Adv Pract Oncol Date: 2015-03-01
Authors: Amélie Harle; Alex Molassiotis; Oliver Buffin; Jack Burnham; Jaclyn Smith; Janelle Yorke; Fiona H Blackhall Journal: BMC Cancer Date: 2020-01-06 Impact factor: 4.430